Ligand Pharmaceuticals Incorporated
LGND
$210.99
$3.191.54%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 186.35% | 202.55% | 7.97% | -32.74% | 50.41% |
| Total Receivables | 59.77% | 44.70% | 35.45% | 70.55% | 33.48% |
| Inventory | -35.34% | -28.91% | -17.05% | -31.51% | -41.12% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -34.31% | -71.22% | 53.64% | 597.73% | 231.43% |
| Total Current Assets | 151.02% | 143.68% | 13.03% | -16.15% | 39.65% |
|
|
|||||
| Total Current Assets | 151.02% | 143.68% | 13.03% | -16.15% | 39.65% |
| Net Property, Plant & Equipment | -25.33% | -56.04% | -54.34% | -56.97% | -61.40% |
| Long-term Investments | -3.52% | -3.52% | -3.52% | -3.52% | 1.82% |
| Goodwill | -3.52% | -3.52% | -3.52% | -3.52% | 1.82% |
| Total Other Intangibles | -15.45% | -15.05% | -11.66% | -11.33% | -11.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.89% | 0.44% | 74.24% | 179.18% | 200.62% |
| Total Assets | 65.71% | 54.66% | 9.49% | -0.92% | 19.63% |
|
|
|||||
| Total Accounts Payable | -38.12% | -21.62% | 378.75% | 183.47% | 115.62% |
| Total Accrued Expenses | 13.89% | 56.60% | 54.04% | 166.67% | 153.01% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -13.26% | -0.09% | -4.71% | -11.96% | 214.63% |
| Total Finance Division Other Current Liabilities | -20.67% | -12.16% | 587.61% | 347.60% | 31.26% |
| Total Other Current Liabilities | -20.67% | -12.16% | 587.61% | 347.60% | 31.26% |
| Total Current Liabilities | 0.90% | 23.28% | 248.69% | 229.35% | 121.14% |
|
|
|||||
| Total Current Liabilities | 0.90% | 23.28% | 248.69% | 229.35% | 121.14% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -27.86% | -29.55% | -27.84% | -31.76% | 1.56% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -18.73% | -44.16% | -23.43% | -43.48% | 7.23% |
| Total Liabilities | 388.10% | 363.20% | 31.65% | 2.38% | 29.00% |
|
|
|||||
| Common Stock & APIC | 18.75% | 17.22% | 50.13% | 56.02% | 69.79% |
| Retained Earnings | 21.87% | 9.08% | -14.12% | -22.51% | -0.80% |
| Treasury Stock & Other | 242.29% | 433.91% | 1,008.45% | -71.76% | -627.29% |
| Total Common Equity | 22.49% | 12.96% | 6.88% | -1.36% | 18.48% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 22.49% | 12.96% | 6.88% | -1.36% | 18.48% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 22.49% | 12.96% | 6.88% | -1.36% | 18.48% |
|
|
|||||